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An adverse drug event (ADE) is a noxious or harmful effect of medications. It is estimated that the incidence of ADEs is approximately 1.7--25.1% at general hospitals. They also result in patient admission with a frequency of 2.0--21.4%.[@bib1], [@bib2] Knowledge improvement regarding ADEs is essential.[@bib3] This will reduce the prevalence, morbidity, and burden of ADEs through early detection and better management of adverse reactions.[@bib4], [@bib5]

Many drugs such as bisphosphonates, topiramate, vigabatrin, quetiapine, retinoids, ethambutol, amiodarone, chloroquine and hydroxychloroquine, tamoxifen, celecoxib, medications used for erectile dysfunction and even herbal medications, are known for their ocular toxicity.[@bib6], [@bib7]

Drug induced ocular events are the second common reason for official complaints against ophthalmologist.[@bib8] Acute ADEs resulting in emergency department visits have a high prevalence.[@bib9] Emergency department admissions due to ADEs are costly and require more health services.[@bib10] The aim of this study was to evaluate the prevalence of ADEs in an ophthalmic specific emergency department in Iran.

Methods {#sec2}
=======

Patients admitted to the emergency department of the Farabi Eye Hospital during 7 days were included. The demographic data, main complaint and present illness, and past medical and drug history of the patients were reviewed. An ophthalmologist and a pharmacist reviewed the diagnosis to find ADE related problem. The national yellow card for the adverse drug reactions (ADRs) was completed for ADE patients. The causality assessment of each ADR was categorized as certain, probable/likely, possible, unlikely, conditional/unclassified, unassessable/unclassifiable based on the World Health Organization (WHO) criteria.[@bib11] Preventability was assessed using the Schumock and Thornton scale.[@bib12] The seriousness of ADRs was assessed by the WHO definition.[@bib11]

Results {#sec3}
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In general, 1631 emergency department visits were recorded. The reason for admission was ADEs in 5 patients (0.3%, 95% CI: 0.13--0.71%). Bilateral but generally asymmetric ocular involvement was found in four of the cases. Four ADEs were caused by tetracaine eye drops (80%, 95% CI: 38--96%). The first patient was a 25-year-old man who had conjunctival injection, corneal edema, and punctate epithelial keratitis in his left eye, one day after inappropriate tetracaine drops administration without a prescription ([Fig. 1](#fig1){ref-type="fig"} A). The causality assessment was "possible". The second case was a 50-year-old man in whom an epithelial defect, infiltration, and punctate epithelial erosion was observed in both eyes, 3 days after using tetracaine drops to control ocular pain after welding without prescription. The causality assessment was "probable". Case 3 was a 66-year-old man with an epithelial defect and corneal edema resulting from the use of tetracaine drops without prescription for 1 day to relieve ocular discomfort following welding. The WHO causality assessment of this ADE was "probable". Case 4 was a 46-year-old man with the complaints of bilateral ocular pain, epiphora, and photophobia. On examination, corneal decompensation with anterior stromal scar formation and neovascularization was found. The right eye had non-healing epithelial defect ([Fig. 1](#fig1){ref-type="fig"} B and C). The problem was caused by tetracaine administration without prescription for 2 days to alleviate foreign body sensation in his eyes. This patient had a history of eye hospital admission for tetracaine ocular adverse effects two years ago. This ADE was the only serious ADR in this study. The causality was "certain". The last patient overused naphazoline eye drops for one month although it was prescribed only for 5 days to treat red eye, resulting in intense injection and hyperemia. Because all 5 patients abused their ocular drops without a prescription, the ADEs were preventable.Fig. 1**A)** Conjunctival injection, corneal edema, and punctate epithelial keratitis in the left eye of a patient with tetracaine drop abuse; **B)** and **C)**, Corneal edema (corneal decompensation), anterior corneal stromal scar, and neovascularization due to tetracaine abuse for sensation of foreign body.Fig. 1

Recovery was the outcome of four ADEs. Only case 4 underwent penetrating keratoplasty on the left eye. None of the patient used any other medications simultaneously.

Discussion {#sec4}
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The evaluation of ADEs in this report revealed that ophthalmic medications could result in emergency department visits. Other studies have shown that emergency department visits due to drug reactions are very frequent and troublesome[@bib13], [@bib14] and most ADEs resulting in emergency department visits are not properly diagnosed.[@bib9]-Proper diagnosis and management of ophthalmic ADEs may reduce ocular complications. As the most prevalent cause of ADE in our study was tetracaine, it seems that education about the hazards of tetracaine drops is necessary both for the pharmacies and the subjects at risk.-Most problems about the local anesthetic eye drop use occurred with self-administration of the drop without physician supervision. This drug may be abused, resulting in corneal complications like corneal opacification, infection, corneal perforation, and visual loss. Local anesthetics may induce a wide range of ophthalmic problems from keratitis to permanent visual acuity reduction.[@bib15] Restriction availability of tetracaine drop without prescription is essential.

This study was performed during a short period of time. Therefore, the incidence of ADEs may be higher. Further long-term studies are recommended to explore the true incidence of the ADEs.
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